Case Studies
Learn more about Biointelect’s diverse work and the profound impact we are making for clients and beyond through our recent project case studies.
Filter
Studies
Pioneering A New Children’s Food Allergy Treatment
With the evolution of biotechnology, addressing allergy treatments for children offers hope for a future where the young can lead
Nanoparticle Drug Reformation: A Biointelect Product Development Strategy
With oncology treatments rapidly growing in interest, the quest to refine and perfect drug delivery mechanisms is paramount. Utilising nanoparticles,
A Regulatory Strategy For Innovative Drug Device Combination
In the realm of drug and device regulations, having a partner to navigate the complexities can significantly alter a company’s
HTA Roadmap For a New Vaccine in Australia
The landscape of vaccines in Australia is marked by stringent guidelines and a competitive marketplace and above all a focus
Streamlining Quality & Safety: Development in QMS and Pharmacovigilance
In the rapidly evolving world of biotech, adhering to global quality and safety standards is paramount.
A US-based biotech company faced
Navigating European Market Access: A Strategic Blueprint for Novel Vaccines
Introduction The European medical market is the second-largest medical device market following the US, requiring newfound innovation for pharmaceutical companies
Developing a Winning Business Case: Securing NHMRC Grant for an Antibiotic Solution
Antibiotic resistance is a looming global health challenge, with the ESKAPE pathogens leading the charge. Amid this urgent need, a
Advancing Viral Vector Manufacturing: The NSW VVMF Initiative
Introduction As the world delves deeper into the complexities of biotechnology, the need for innovative facilities that can accelerate this
Innovating the RNA Landscape: A Case Study Of The NSW RNA Pilot Manufacturing Facility
In an era of rapid advancements in medical technology, the journey to propel RNA therapeutics to the forefront of healthcare
Bringing Antimalarial Tafenoquine To US and Australian Markets
Antimalarial drugs have been instrumental in saving millions of lives. Yet, with the rise of resistance to existing medications, there
With the rapid and ongoing global growth of cell and gene (C&G) products, there is an opportunity for Australia to...
The current healthcare environment in Australia offers various opportunities for stakeholders, including patients, to engage with the health system and...
As the world emerges from the pandemic, it is critical to reflect on what has been learned and how to...
Horizon scanning is a process or system which seeks to systematically identify and assess the potential impact of new and...
Discount rates reflect how society values future outcomes compared to present outcomes. When applied to medicines, inappropriately high discount rates...
This white paper examines the challenges and barriers to achieving higher rates of vaccination among Australian adults eligible for the...